{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-284002","form_type":"8-K","ticker":"WVE","cik":"0001631574","company_name":"Wave Life Sciences Ltd.","filed_at":"2026-06-26T12:30:06+00:00","discovered_at":"2026-06-26T12:35:00.356824+00:00","generated_at":"2026-06-26T12:35:24.580599+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Wave Life Sciences shareholders approve redomiciliation; 155M shares voted in favor","bullets":["Scheme Shareholders voted 155,190,836 for (99.9%) and 78,429 against; all 87 shareholders voted in favor.","Redomiciliation expected to take effect in mid-2026, subject to Singapore High Court approval.","Scheme of Arrangement approved under Singapore law; company to seek court confirmation."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-284002","json":"https://secwatch.observer/filing/0001193125-26-284002.json","markdown":"https://secwatch.observer/filing/0001193125-26-284002.md","text":"https://secwatch.observer/filing/0001193125-26-284002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526284002/0001193125-26-284002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526284002/d70732d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T12:35:24.580599+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}